Workflow
特种分离膜组件
icon
Search documents
嘉戎技术跌2.26% 2022年上市募11亿国投证券保荐
Zhong Guo Jing Ji Wang· 2025-11-13 08:09
Core Points - The stock of Jiarong Technology (301148.SZ) closed at 32.48 yuan, down 2.26%, with a total market capitalization of 3.784 billion yuan, currently in a state of decline [1] - Jiarong Technology was listed on the Shenzhen Stock Exchange's ChiNext board on April 21, 2022, with an initial offering price of 38.39 yuan per share [1] - The company raised a total of 1.118 billion yuan through its initial public offering (IPO), with a net fundraising amount of 989 million yuan, exceeding the original plan by 27.33 million yuan [2] Fundraising and Use of Proceeds - The funds raised are intended for projects including the industrialization of high-performance membrane materials, expansion of DTRO membrane component production capacity, industrialization of special separation membrane components, research center construction, operational network development, and working capital supplementation [2] - The total issuance costs amounted to 129 million yuan, with the underwriting fees for Anxin Securities accounting for 103 million yuan and the sponsorship fees being 2 million yuan [2] Stock Performance - On the second day of trading, April 22, 2022, Jiarong Technology reached an intraday high of 39.99 yuan, marking the highest price since its listing [2]
嘉戎技术: 国投证券股份有限公司关于厦门嘉戎技术股份有限公司2025年半年度募集资金存放与使用情况的专项核查报告
Zheng Quan Zhi Xing· 2025-08-27 14:02
Core Viewpoint - The report outlines the fundraising and usage status of Xiamen Jiarong Technology Co., Ltd. as of June 30, 2025, highlighting compliance with regulatory requirements and detailing the management of raised funds [1][3]. Fundraising Overview - The company raised a total of RMB 1,118.30 million through the issuance of 29.13 million shares at a price of RMB 38.39 per share, with a net amount of RMB 989.01 million after deducting issuance costs of RMB 129.29 million [1][2]. - The funds were deposited into a designated bank account on April 18, 2022, and verified by an accounting firm [1]. Fund Usage and Balance - As of June 30, 2025, the company directly invested RMB 1.66 million in fundraising projects during the reporting period, with a total of RMB 48.70 million invested cumulatively [5][8]. - The company has a cash management balance of RMB 53.10 million from idle funds, which is being used for high-security, liquid financial products [5][9]. Fund Management Practices - The company has established a fundraising management method to ensure the proper storage, approval, usage, and supervision of the raised funds, adhering to principles of regulation, safety, efficiency, and transparency [2][3]. - The company signed tripartite supervision agreements with several banks to clarify the rights and obligations of all parties involved in the management of the raised funds [3][4]. Project Implementation and Adjustments - The company has made adjustments to the implementation timelines of several projects, extending deadlines to December 31, 2025, due to external macroeconomic factors and operational challenges [8][9]. - The company plans to enhance its project implementation locations and structures to better support its long-term development strategy [8][9]. Compliance and Reporting - The company has complied with the relevant regulations and has disclosed the usage of raised funds in a timely manner, with no violations reported regarding the management of these funds [8][9].